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Benzene is carcinogenic, whereas toluene is thought to have little carcinogenic potential.
Benzene and toluene were found to activate cyclin-dependent kinase 2 in rat liver epithelial (RLE)
and HL60 cells. pRbl 05 was hyperphosphorylated in RLE cells treated with either solvent. Kinase
activation and subsequent hyperphosphorylation of pRbl 05 and p53 by benzene or toluene may
be responsible for their growth promotional effects, but it does not account for increased
potential of benzene to induce cancer. Therefore, we examined the ability of these solvents to
increase p53-DNA site-specific binding in RLE cells. Benzene increased p53-DNA site-specific
DNA binding in RLE cells compared to control levels or the effects of toluene. Increased
p53-DNA site-specific binding by benzene may be caused by damage to cellular DNA. If so,
although both solvents appear to have promotional activity, the increased potential of benzene to
damage DNA may be responsible to the difference in the ability of benzene to cause cancer.
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Key words: p53, pRbl 05, tumor promoter, phosphorylation, DNA damage, cyclin-dependent
kinase
Introduction
Recently, we showed that benzene, toluene,
and chloroform induce hyperphosphoryla-
tion of the tumor-suppressor gene product
p53 (1). Hyperphosphorylation ofp53 and
pRb105 by promoters like 12-O-tetrade-
canoylphorbol-13-acetate (TPA), benzene,
toluene and chloroform is probably due to
their effects via protein kinase C (PKC) or
by inducing a cascade effect in kinases
responsible for signal transduction (1-4).
Stimulation ofkinase activity and the sub-
sequent hyperphosphorylation of tumor-
suppressor gene products, may partially
account for the promotional effects exhib-
ited by benzene, toluene, and chloroform.
Promoter attenuation of p53's ability to
induce cell cycle arrest may also keep p53
from preventing the replication ofdamaged
DNA (5). Therefore, posttranslational
modification of p53 or other tumor-sup-
pressor gene products induced by benzene
or toluene may also be a factor in deter-
mining the relative carcinogenicity of the
two solvents.
Since benzene and toluene both appear
to have adverse effects on molecular mecha-
nisms that control cell growth and prevent
the duplication of genetic errors, these
effects do not explain the apparent differ-
ences in the ability of the two solvents to
cause cancer. It is clear that benzene is a car-
cinogen, but toluene is thought to be either
noncarcinogenic or to have little potential
to induce cancer in hematopoietic cells.
To resolve the difference in the carcino-
genic potential ofbenzene and toluene, we
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examined the ability of these two solvents
to induce cyclin-dependent kinase 2 (Cdk2)
activity and to hyperphosphorylate pRb1O5.
Cdk2 has been previously associated with
the promotional effects of estrogen and
phosphorylates the tumor-suppressor gene
product pRblO5 (6). We hypothesized
that differences in kinase induction and
post translation modification of proteins
like pRblO5 might account for the appar-
ent differences in carcinogenicity shown by
benzene and toluene. Hyperphosphoryla-
tion of pRblO5 was examined in rat liver
epithelial (RLE) and HL60 cells that had
been treated with benzene or toluene.
Cdk2 kinase activity in cells treated with
benzene and toluene was also determined.
Previous studies have also suggested
that p53 DNA site-specific DNA binding
is increased in cells treated with DNA-
damaging agents and chemotherapeutic
agents (7). We hypothesized that the abil-
ity to damage DNA might be responsible
for the apparent differences in carcinogenic
potential ofbenzene and toluene. Therefore,
we examined p53-DNA binding in RLE
cells treated with toluene or benzene.
Materials and Methods
Cell lines examined in this study included
WB-F344 RLE cells, which were a gift
from Dr. James Trosko ofMichigan State
University (1). Because RLE cells appear to
produce a wild-type p53 and pRblO5 (8),
they were used for immunoprecipitation of
pRblO5, Cdk2, and p53-DNA sequence-
specific binding studies. Because the HL60
cells, obtained from the American Type
Culture Collection, produce mutant p53
and the pRblO5 status is unknown, they
were only examined for Cdk2 activation.
RLE cells were maintained in Richter's
medium, and HL6O cells were maintained
in RPMI 1640. Both cell lines were incu-
bated at 37°C in a 5% CO2 atmosphere.
RLE cells were maintained with 5% (v/v)
calf serum and HL60 cells in 20% fetal
bovine serum. Prior to studies on Cdk2 acti-
vation, the respective serum concentrations
were reduced to 0.5% (v/v) for 48 hr.
Hyperphosphorylation of pRb105 in
RLE cells was examined by adding 0 to 2%
(v/v) benzene or toluene to the medium of
the adherent cells similar to procedures
described previously (1). Briefly, pRblO5
was radiolabeled using [32P]-ortho-phos-
phoric acid and the cells were lysed (1).
pRblO5 was immunoprecipitated (1). Total
protein ofall extracts was determined using
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a commercial BCA protein assay (Pierce
Biochemicals, Rockford, IL). Samples were
equalized on total protein before immuno-
precipitations were performed. Anti-
pRb105 monoclonal antibody was obtained
from Oncogene Sciences (Manhassett,
NY). Radiolabeled cell extracts were incu-
bated with the antibody and protein A/G
agarose overnight. The agarose immune
complexes were precipitated using micro-
centrifugation, and then the supernatants
were removed and discarded. The agarose
beads were washed with lysis buffer and
then centrifuged. Standard denaturing gel
sample buffer was added, and the immuno-
precipitates examined using denaturing gel
electrophoresis followed by autoradiogra-
phy. Polyacrylamide gels used were 8.0%
from a commercial source (Novex Inc.,
San Diego, CA). Immunoprecipitation
studies were performed similar to the
kinase assay protocols except [35S]-methio-
nine labeled extracts from RLE cells were
used (1). Anti-p53 (ab-1) and anti-heat
shock protein (HSP) 72/73 were obtained
from Oncogene Sciences.
RLE or HL60 cells were washed twice
with ice-cold phosphate-buffered saline
(PBS) and lysed by the addition of cold
lysis buffer (Tris 20 mM pH 7.5, NaCl
250 mM, 0.1% NP-40, NaF 10 mM,
sodium vanidate [NaVO] 1 mM, phenyl-
methylsulfonylfluoride [PMSF] 1mM).
After 15 min on ice, the lysates were cen-
trifuged at 20,000g for 15 min (4°C).
Cdk2 was precipitated from equal amounts
ofcell extracts using purified rabbit anti-
Cdk2 (Santa Cruz Biotechnology, Santa
Cruz, CA) and protein A/G agarose. Cdk2
immunoprecipitates were washed (3x) with
the lysis buffer and twice with kinase buffer
(Tris 40 mM, pH 7.5, MgCl2 10 mM).
The immunoprecipitates were suspended
in 30 p1l of kinase buffer supplemented
with 400 pg/mi histones (type II-SS, Sigma
chemical, St. Louis, MO), 5 pM ATP, 0.5
pM dithiothreitol, 0.5 mM EGTA, and 5
pCi y-[32P]-ATP for 20 min at room tem-
perature. The reaction was stopped using
gel electrophoresis sample buffer, and the
reaction products were separated on a 14%
polyacrylamide gel (Novex).
Cells were cultured in 175-cm2 flasks in
Richter's medium supplemented with 0.5%
calf serum. The medium was replaced
before adding compounds for test with
fresh medium without serum. Cells were
then incubated for 2 hr. Untreated control
cells were also examined. Nuclear extracts
from the cells were prepared as described
(5). Briefly, the medium was removed
from the cells, and the monolayers were
washed with PBS, pH 7.4. Cells were lysed
by the addition of 2.5 ml buffer (20%
glycerol, 10 mM NaCl, 1.5 mM MgC12,
0.2 mM EDTA, 1 mM dithiothreitol, 1
mM PMSF, and 0.1% Triton X-100 in 20
mM HEPES buffer, pH 7.6). The lysate
was centrifuged at 800gfor 4 min and the
resulting pellet was diluted with 3 vol of
500 mM NaCl in buffer (see above) and
then incubated at 4°C for 30 min with agi-
tation. The mixture was centrifuged at
35,000g for 10 min and the supernatants
containing p53 were removed for immedi-
ate analysis. The total protein content of
the extracts was determined using BCA
protein assays (Pierce Biochemicals).
Protein content for all samples was equal-
ized before performing the binding assay.
The consensus p53 binding sequence
determined by Funk (GGACATGCC-
CGGGCATGTCC) (9) was synthesized,
prepared in double-stranded form, and
end-labeled with [32P]-ATP. Binding reac-
tions consisted of 20 pg nuclear protein,
0.5 ng 32P-labeled oligonucleotide, 0.5 pg
salmon sperm DNA (Sigma) with buffer
(without Triton) in a final volume of25 pl.
Binding reactions were incubated at room
temperature for 20 min and 8 pl of the
reaction mixtures were separated on 6%
nondenaturing polyacrylamide gels (Novex)
and visualized by autoradiography.
Results
To determine ifpRblO5 was hyperphos-
phorylated in RLE cells treated with
benzene or toluene, we treated RLE cells
with concentrations of solvent ranging
from 0 to 2% (v/v). Phosphorylation of
p53 in RLE cells increases with the dose of
benzene (Figure la) or toluene (Figure lb)
applied to the cells. Therefore, RLE cells
hyperphosphorylate pRblO5 in a dose-
dependent response to the solvents.
Figure 1. (a) Phosphorylation of pRblO5 in rat liver
epithelial (RLE) cells increases with the applied dose of
benzene. (b) Phosphorylation of pRblO5 RLE cells also
increases with the applied dose of toluene. Benzene
and toluene were added to the medium at a concentra-
tion of2% (v/v) and incubated with the cells for2 hr.
Figure 2. (a) Activation of cyclin-dependent kinase 2
(Cdk2) occurs in rat liver epithelial (RLE) cells treated
with benzene in relation to the applied dose. (b) Cdk2
activation also occurs when the HL60 cells are treated
with benzene. Lanes 1 contain histone incubated with
immunoprecipitated Cdk2 from cell extracts from con-
trol cells (no solvent); lanes 2, cells treated with
0.125%; lanes 3, 0.25%; lanes 4, 0.5%; lanes 5, 1.0%;
lanes 6, 2% (v/v). RLE cells were incubated in medium
containing benzene for 4 and 2 hrfor HL60 cells.
Cdk2 activity increases in relation to
the applied dose of benzene (Figure 2a)
added to the medium of RLE or to HL60
cells (Figure 2b). Similar dose-dependent
increases in Cdk2 activity are obtained
when using toluene (data not shown).
Differences in the amount ofCdk2 activa-
tion may be caused by different suscepti-
bilities of the cells to the two solvents.
However, it cannot be determined if this
variation is caused by some feature of the
experimental methods used. Since the sol-
vents are not fully miscible in the medium,
the applied dose under these conditions is
difficult to control. In addition, the sol-
vents, especially at high doses, may also be
highly toxic to the cells. Longer application
ofthe solvents at 1 or 2% (v/v) resulted in
toxic death ofRLE cells.
DNA-damaging and chemotherapeutic
agents increase p53-DNA site-specific bind-
ing in RLE cells (Figure 3A). Benzene treat-
ment of RLE cells was found to increase
p53-DNA binding when compared to con-
trol cells (Figure 3B). p53-DNA binding
was also increased over control levels in
cells treated with toluene (Figure 3B), but
the effect was markedly less than that
produced by benzene.
Increased amounts of HSP 72/73 is
precipitated from benzene- and toluene-
treated RLE cells using the anti-HSP72/73
antibody (Figure 4). However, it cannot be
determined ifanti-HSP coprecipitates p53
oranti-p53 coprecipitates HSP.
Discussion
Since benzene and toluene have been pre-
viously shown to be potent PKC-activating
promoters, it is likely that the hyperphos-
phorylation of p53 is mediated through
effects on PKC as has been previously
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Figure 3. (A) DNA-damaging chemicals and chemotherapeutic agents increase p53-DNA site-specific DNA bind-
ing in rat liver epithelial (RLE) cells. (B) Increased p53-DNA site-specific binding occurs when RLE cells are treated
with 2% benzene or toluene. Little or no increase in p53-DNA binding occurs when 1% benzene or toluene is
added to the medium.
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Figure 4. Increased amounts of heat-shock protein
(HSP) are precipitated from rat liver epithelial (RLE) cells
treated with 2% benzene and to a lesser extent from
toluene-treated cells byanti-HSP antibody. No evidence
of coprecipitation of HSP was found when anti-p53
antibody was used. Cells were incubated in medium
containing solventfor 2 hrbefore detergent lysis.
demonstrated for phorbol 12-myristate
13-acetate (PMA) (1-4). Results presented
here suggest that the growth promotional
effects ofbenzene and toluene may in part
be caused by hyperphosphorylating another
cell cycle and transcription controlling pro-
tein pRbIO53. This result is in agreement
with studies that show PMA treatment of
cells results in the hyperphosphorylation of
p53 and pRblO5 (1,10). Results presented
here suggest that Cdk2 activation is
responsible for the hyperphosphorylation
ofpRb105. It remains to be determined if
benzene or toluene directly affect Cdk2 or
this is a result ofa cascade effect on signal
transduction enzymes.
Other growth-stimulating promoters
also have been shown to increase Cdk2
activity. Estradiol stimulates Cdk2 in
cultured human breast cells and increases
the phosphorylation ofpRb105 (6). The
xenoestrogen DDT also increases Cdk2
activity (10). Hyperphosphorylation of
pRblO5 and p53 that occurs as a result of
the effects ofchemical promoters on kinase
activity may be an essential component of
their growth-stimulating properties.
Hyperphosphorylation of p53, for exam-
ple, has been shown to decrease the ability
ofp53 to activate transcription (11).
No outstanding differences between the
ability ofbenzene or toluene to phosphory-
late pRb105 or induce Cdk2 activation
were found that might explain the differ-
ence in the carcinogenic potential ofthese
two solvents. However, p53-sequence-
specific DNA binding was found to be
elevated in cells treated with 2% benzene
when compared to cells treated with toluene
or control cells. Increased p53 DNA site-
specific DNA binding has been demon-
strated in cells treated with DNA-damaging
or chemotherapeutic agents that affect
DNA-manipulating enzymes (5). DNA-
damaging chemicals and chemotherapeutic
agents increase p53-DNA binding in RLE
cells (Figure 3A), as do high concentrations
(2% v/v) ofbenzene (Figure 3B), and to a
lesser extent, toluene (Figure 3B). Lower
concentrations of toluene or benzene (1%
v/v) fail to markedly increase p53-DNA
binding in RLE cells (Figure 3B). If ben-
zene-induced increase in p53 DNA site-
specific DNA binding can be attributed to
a molecular mechanism occurring in
response to DNA damage (5), benzene
may be more capable ofdamaging genetic
material. Therefore, this may account for
the carcinogenicity demonstrated by
benzene in relation to toluene. However,
other cellular stresses including hypoxia
have also been shown to increase p53-DNA
binding, but the increased p53 levels are
thought to occur by a different mechanism
than radiation-induced DNA damage (12).
The tumor promoter okadiac acid, an
inhibitor ofprotein phosphatases, has been
shown to also increase the steady-state level
ofp53 without altering p53-DNA binding
(13). Heat shock has been shown to
increase the intracellular levels of p53,
which is bound by heat shock protein
(14). Therefore, cellular effects by benzene
that result in stress may be responsible for
the increase we see in p53-DNA binding.
Increased levels of HSP were precipitated
from benzene- and toluene-treated cells
(Figure 4). However, no evidence ofcopre-
cipitation ofp53 by anti-HSP or precipita-
tion of HSP by anti-p53 could be found.
Therefore, we cannot attribute the change
in p53-DNA binding in solvent-treated
cells to HSP, nor can we rule it out. What-
ever cellular stress is indicated by increased
p53-DNA binding after treatment ofben-
zene that is not evident with toluene, it still
may represent a central difference between
the two solvents that is directly related to
carcinogenicity. Further studies will be
required to determine ifbenzene-induced
p53-DNA binding is directly related to
DNA damage or is caused by some other
form ofcellular stress.
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